Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

11.67
+0.33002.91%
Volume:1.70M
Turnover:19.67M
Market Cap:1.86B
PE:262.86
High:11.76
Open:11.42
Low:11.28
Close:11.34
52wk High:42.44
52wk Low:11.25
Shares:159.53M
Float Shares:70.11M
Volume Ratio:1.05
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0444
EPS(LYR):0.0444
ROE:3.29%
ROA:0.24%
PB:7.19
PE(LYR):262.86

Loading ...

Piper Sandler Downgrades Vertex to Neutral From Overweight

MT Newswires Live
·
Feb 03

Vertex Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Feb 03

Vertex Minerals Reaffirms JORC-Compliant Gold Resource Position at Reward Mine

TIPRANKS
·
Feb 03

Vertex Minerals Strengthens Leadership to Drive Reward Gold Mine Production Ramp-Up

TIPRANKS
·
Feb 02

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jan 31

Vertex Ramps Up Underground Production at Reward Gold Mine and Bolsters Funding

TIPRANKS
·
Jan 30

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Fund Exit And Setback For Journavx Pain Label

Simply Wall St.
·
Jan 29

Vertex Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Jan 28

Vertex Pharmaceuticals assumed with Overweight from Equal Weight at Barclays

TIPRANKS
·
Jan 28

Vertex Pharmaceuticals (VRTX) Receives a Buy from Citi

TIPRANKS
·
Jan 27

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 27

Vertex Pharmaceuticals Is Maintained at Buy by UBS

Dow Jones
·
Jan 27

Vertex Pharmaceuticals price target raised to $545 from $535 at UBS

TIPRANKS
·
Jan 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (CORT), Intuitive Surgical (ISRG) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jan 23

Vertex Pharmaceuticals price target raised to $530 from $475 at Evercore ISI

TIPRANKS
·
Jan 23

Vertex Pharmaceuticals gets orphan status for membranous nephropathy treatment

TIPRANKS
·
Jan 23

Vertex Pharmaceuticals Poised for Higher Valuation on Povetacicept, Cystic Fibrosis Pipeline, RBC Says

MT Newswires Live
·
Jan 23

Vertex Pharmaceuticals Raised to Outperform From Sector Perform by RBC Capital

Dow Jones
·
Jan 22